trial · primary record
Rilzabrutinib dose 1
Graves' Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2027-03-11 |
| Primary endpoint | Percent change from baseline in FT4 levels |
| Registry ID | NCT06984627 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:08.951Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06984627
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.